Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Matthew McCallum, Anna De Marco, Florian A. Lempp, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang, Manoj S. Nair, Lihong Liu, et al.
Nature (2021) Vol. 593, Iss. 7857, pp. 130-135
Open Access | Times Cited: 2239
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
Constantinos Kurt Wibmer, Frances Ayres, Tandile Hermanus, et al.
Nature Medicine (2021) Vol. 27, Iss. 4, pp. 622-625
Open Access | Times Cited: 1233
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Rita E. Chen, Xianwen Zhang, James Brett Case, et al.
Nature Medicine (2021) Vol. 27, Iss. 4, pp. 717-726
Open Access | Times Cited: 970
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Dami A. Collier, Anna De Marco, Isabella A. T. M. Ferreira, et al.
Nature (2021) Vol. 593, Iss. 7857, pp. 136-141
Open Access | Times Cited: 692
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Leonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, et al.
Science (2021) Vol. 372, Iss. 6549, pp. 1413-1418
Open Access | Times Cited: 573
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Bo Meng, Steven A. Kemp, Guido Papa, et al.
Cell Reports (2021) Vol. 35, Iss. 13, pp. 109292-109292
Open Access | Times Cited: 412
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study
Kathryn M. Hastie, Haoyang Li, Daniel Bedinger, et al.
Science (2021) Vol. 374, Iss. 6566, pp. 472-478
Open Access | Times Cited: 289
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
Constantinos Kurt Wibmer, Frances Ayres, Tandile Hermanus, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 283
A human coronavirus evolves antigenically to escape antibody immunity
Rachel Eguia, Katharine H. D. Crawford, Terry Stevens-Ayers, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 4, pp. e1009453-e1009453
Open Access | Times Cited: 221
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Ivana Lazarević, Vera Pravica, Danijela Miljanovic, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1192-1192
Open Access | Times Cited: 183
Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies
Lianlian Bian, Fan Gao, Jialu Zhang, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 4, pp. 365-373
Open Access | Times Cited: 168
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies
Dami A. Collier, Anna De Marco, Isabella A. T. M. Ferreira, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 166
SARS-CoV-2 one year on: evidence for ongoing viral adaptation
Thomas P. Peacock, Rebekah Penrice-Randal, Julian A. Hiscox, et al.
Journal of General Virology (2021) Vol. 102, Iss. 4
Open Access | Times Cited: 166
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
Sandile Cele, Inbal Gazy, Laurelle Jackson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 150
Evolutionary trajectory of SARS-CoV-2 and emerging variants
Jalen Singh, Pranav Pandit, Andrew G. McArthur, et al.
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 141
Increased transmission of SARS-CoV-2 lineage B.1.1.7 (VOC 2020212/01) is not accounted for by a replicative advantage in primary airway cells or antibody escape
Jonathan C. Brown, Daniel H. Goldhill, Jie Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 96
Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies
Marta Alenquer, Filipe Ferreira, Diana Lousa, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 8, pp. e1009772-e1009772
Open Access | Times Cited: 93
SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies
Michael Diamond, Rita Chen, Xuping Xie, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 86
Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York
Anthony P. West, Joel O. Wertheim, Jade Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 73
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
Nicholas K. Hurlburt, Leah J. Homad, Irika Sinha, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 66
Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice
Shihui Sun, Lei He, Zhongpeng Zhao, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 4, pp. 1070-1073
Open Access | Times Cited: 65
SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies
Ceri A. Fielding, Pragati Sabberwal, James C. Williamson, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 61
Deep mutational scans of XBB.1.5 and BQ.1.1 reveal ongoing epistatic drift during SARS-CoV-2 evolution
Ashley L. Taylor, Tyler N. Starr
PLoS Pathogens (2023) Vol. 19, Iss. 12, pp. e1011901-e1011901
Open Access | Times Cited: 29
Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization
Li Zhang, Zhimin Cui, Qianqian Li, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 54
COVID-19, the first pandemic in the post-genomic era
Lucy van Dorp, Charlotte J. Houldcroft, Damien Richard, et al.
Current Opinion in Virology (2021) Vol. 50, pp. 40-48
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top